A bill to establish a Biopharmaceutical Center of Excellence, and for other purposes.
In Committee
Introduced:Nov 18, 2025
Primary Sponsor
Chris Van Hollen
Senator
Democratic
MD
Cosponsors
2
Quick Stats
Policy Area
Social Welfare
Summary
This bill would establish a National Biopharmaceutical Manufacturing Center of Excellence to advance the science and technology of biopharmaceutical manufacturing in the United States. The center would work to develop new manufacturing techniques, support good manufacturing practices, and train the workforce needed for the biotechnology industry.
Latest Action
Read twice and referred to the Committee on Finance.
AI Summary
Plain-English explanation of this bill
This bill would establish a National Biopharmaceutical Manufacturing Center of Excellence to advance the science and technology of biopharmaceutical manufacturing in the United States. The center would work to develop new manufacturing techniques, support good manufacturing practices, and train the workforce needed for the biotechnology industry.
Last updated: 12/29/2025
Official Summary
Congressional Research Service summary
<p><strong>Helping Students Successfully Overcome Adversity and Rise with Social Security Act or the Helping Students SOAR with Social Security Act</strong></p> <p>This bill allows an eligible child of a retired, disabled, or deceased worker to receive applicable Social Security benefits on the worker's record until age 26 if the child is in at least half-time attendance as a student at a postsecondary school or a comprehensive transition and postsecondary program. </p> <p>Under current law, a child's Social Security benefits generally terminate at age 18, although (1) a child who is a full-time elementary or secondary school student may receive benefits until age 19, and (2) a child with a disability that began before age 22 may continue receiving benefits after the age of 18. </p>
Key Points
Main provisions of the bill
Establishes a new National Biopharmaceutical Manufacturing Center of Excellence to drive innovation in biopharmaceutical manufacturing
The center would work to develop flexible and efficient manufacturing processes, support quality control practices, and train the biotechnology workforce
The goal is to reduce US reliance on foreign supply chains and ensure the country can rapidly produce critical medicines and other biotechnology products
How This Impacts Americans
Potential effects on citizens and communities
If passed, this bill would primarily benefit the US biotechnology and pharmaceutical industries by providing funding and resources to improve domestic manufacturing capabilities. It could lead to the creation of new high-tech jobs in the biomanufacturing sector and help ensure the US can produce important medical treatments and other biotechnology products without relying on foreign suppliers.
Policy Areas
Primary Policy Area
Social Welfare
Scope & Jurisdiction
Jurisdiction Level
federal
Congressional Session
119th Congress
Citation Reference
3188, 119th Congress (2025). "A bill to establish a Biopharmaceutical Center of Excellence, and for other purposes.". Source: Voter's Right Platform. https://votersright.org/bills/118-s-3188
